Literature DB >> 17164769

Integrating DNA vectors for gene therapy.

Perry B Hackett1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17164769      PMCID： PMC1865132          DOI： 10.1038/sj.mt.6300065

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  10 in total

1.  Phi c31 integrase induces chromosomal aberrations in primary human fibroblasts.

Authors:  J Liu; I Jeppesen; K Nielsen; T G Jensen
Journal:  Gene Ther       Date:  2006-05-04       Impact factor: 5.250

Review 2.  Transforming science: cancer gene identification.

Authors:  Lara S Collier; David A Largaespada
Journal:  Curr Opin Genet Dev       Date:  2005-12-01       Impact factor: 5.578

3.  Integration specificity of phage phiC31 integrase in the human genome.

Authors:  Thomas W Chalberg; Joylette L Portlock; Eric C Olivares; Bhaskar Thyagarajan; Patrick J Kirby; Robert T Hillman; Juergen Hoelters; Michele P Calos
Journal:  J Mol Biol       Date:  2005-12-22       Impact factor: 5.469

4.  Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells.

Authors:  Z Ivics; P B Hackett; R H Plasterk; Z Izsvák
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

5.  Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.

Authors:  S R Yant; L Meuse; W Chiu; Z Ivics; Z Izsvak; M A Kay
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

6.  Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.

Authors:  Sheng Ding; Xiaohui Wu; Gang Li; Min Han; Yuan Zhuang; Tian Xu
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

7.  Site-specific genomic integration produces therapeutic Factor IX levels in mice.

Authors:  Eric C Olivares; Roger P Hollis; Thomas W Chalberg; Leonard Meuse; Mark A Kay; Michele P Calos
Journal:  Nat Biotechnol       Date:  2002-10-15       Impact factor: 54.908

8.  Complete and persistent phenotypic correction of phenylketonuria in mice by site-specific genome integration of murine phenylalanine hydroxylase cDNA.

Authors:  Li Chen; Savio L C Woo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

Review 9.  Sleeping beauty transposition: biology and applications for molecular therapy.

Authors:  Zsuzsanna Izsvák; Zoltán Ivics
Journal:  Mol Ther       Date:  2004-02       Impact factor: 11.454

10.  Harnessing a high cargo-capacity transposon for genetic applications in vertebrates.

Authors:  Darius Balciunas; Kirk J Wangensteen; Andrew Wilber; Jason Bell; Aron Geurts; Sridhar Sivasubbu; Xin Wang; Perry B Hackett; David A Largaespada; R Scott McIvor; Stephen C Ekker
Journal:  PLoS Genet       Date:  2006-08-28       Impact factor: 5.917
  10 in total
  21 in total

1.  Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells.

Authors:  Xin Huang; Hongfeng Guo; Syam Tammana; Yong-Chul Jung; Emil Mellgren; Preetinder Bassi; Qing Cao; Zheng Jin Tu; Yeong C Kim; Stephen C Ekker; Xiaolin Wu; San Ming Wang; Xianzheng Zhou
Journal:  Mol Ther       Date:  2010-07-06       Impact factor: 11.454

2.  Long-term and efficient expression of human β-globin gene in a hematopoietic cell line using a new site-specific integrating non-viral system.

Authors:  K Dormiani; H Mir Mohammad Sadeghi; H Sadeghi-Aliabadi; K Ghaedi; M Forouzanfar; H Baharvand; M H Nasr-Esfahani
Journal:  Gene Ther       Date:  2015-04-01       Impact factor: 5.250

Review 3.  Preparing clinical grade Ag-specific T cells for adoptive immunotherapy trials.

Authors:  D L DiGiusto; L J N Cooper
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

Review 4.  Transposon tools hopping in vertebrates.

Authors:  Jun Ni; Karl J Clark; Scott C Fahrenkrug; Stephen C Ekker
Journal:  Brief Funct Genomic Proteomic       Date:  2008-11

5.  Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.

Authors:  Teiko Sumiyoshi; Nathalia G Holt; Roger P Hollis; Shundi Ge; Paula M Cannon; Gay M Crooks; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2009-12       Impact factor: 5.695

Review 6.  The Sleeping Beauty transposon system: a non-viral vector for gene therapy.

Authors:  Elena L Aronovich; R Scott McIvor; Perry B Hackett
Journal:  Hum Mol Genet       Date:  2011-04-01       Impact factor: 6.150

7.  Duration of expression and activity of Sleeping Beauty transposase in mouse liver following hydrodynamic DNA delivery.

Authors:  Jason B Bell; Elena L Aronovich; Jeffrey M Schreifels; Thomas C Beadnell; Perry B Hackett
Journal:  Mol Ther       Date:  2010-07-13       Impact factor: 11.454

Review 8.  A new approach to gene therapy using Sleeping Beauty to genetically modify clinical-grade T cells to target CD19.

Authors:  Harjeet Singh; Helen Huls; Partow Kebriaei; Laurence J N Cooper
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 9.  Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.

Authors:  Perry B Hackett; David A Largaespada; Kirsten C Switzer; Laurence J N Cooper
Journal:  Transl Res       Date:  2013-01-10       Impact factor: 7.012

10.  Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system.

Authors:  Elena L Aronovich; Jason B Bell; Shaukat A Khan; Lalitha R Belur; Roland Gunther; Brenda Koniar; Patricia A Schachern; Josh B Parker; Cathy S Carlson; Chester B Whitley; R Scott McIvor; Pankaj Gupta; Perry B Hackett
Journal:  Mol Ther       Date:  2009-04-21       Impact factor: 11.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.